Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: RESILIENCE GOVERNMENT SERVICES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-09 to 2023-11-30
Current total value of award: $9634984
Description: PRODUCTION OF A MAB-BASED THERAPEUTIC DIRECTED AGAINST A BROAD SPECTRUM OF HIGHLY DIVERSE BOTULINUM NEUROTOXIN SEROTYPE F SUBTYPES AND DISCOVERY WORK OF MAB AGAINST BOTULINUM NEUROTOXIN SEROTYPE G.